Women’s Advanced Cardiovascular Risk Panel
An advanced women’s cardiovascular risk panel evaluating lipid particles, ApoA1/ApoB ratio, Lipoprotein (a), inflammation (hs-CRP), homocysteine, fibrinogen, galectin-3, insulin resistance, thyroid function, kidney health, leptin, adiponectin, vitamin D, ferritin, and more. Designed to provide a comprehensive cardiometabolic profile beyond standard cholesterol testing.
- $2,197.36
- $579
- Save: 73.65%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Adiponectin
Apolipoprotein A1
Apolipoprotein B
Apolipoprotein B/A1 Ratio
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
CYSTATIN C
eGFR
Ferritin
Also known as: Factor I, Fibrinogen, Fibrinogen Activity Clauss
Fibrinogen Activity,
GALECTIN 3
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: Homocysteine, Homocysteine Cardiovascular
HOMOCYSTEINE,
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Insulin (fasting)
Insulin
Leptin
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Lipoprotein A, Lp (a), Lp(a)
Lipoprotein (A)
HDL P
HDL SIZE
LARGE HDL P
LARGE VLDL P
LDL P
LDL SIZE
SMALL LDL P
VLDL SIZE
Also known as: Free T4, FT4, T4 Free
T4, Free
Also known as: Thyroid Stimulating Hormone Test, Thyrotropin Test
TSH
Also known as: ,25-Hydroxyvitamin D2, 25-Hydroxycholecalciferol (25OHD3), 25-OH-D2,D3 Vitamin, D2 Vitamin,25-Hydroxyvitamin D3,25-OH-D3, QuestAssureD 25Hydroxyvitamin D D2 D3 LCMSMS, Vitamin D, Vitamin D, 25-Hydroxy, Vitamin D2, 25-hydroxy,25-Hydroxyergocalciferol (25OHD2),Vitamin D3, 25-hydroxy
Vitamin D, 25-Oh, Total
The Women’s Advanced Cardiovascular Risk Panel panel contains 20 tests with 87 biomarkers .
A Comprehensive, Advanced Cardiovascular and Metabolic Risk Assessment for Women
The Women’s Advanced Cardiovascular Risk Panel is an in-depth blood testing panel designed to evaluate cardiovascular health, metabolic function, inflammation, hormonal balance, kidney health, and cardiometabolic signaling markers in women. By combining traditional lipid testing with advanced lipoprotein analysis, inflammatory biomarkers, adipokines, and kidney filtration markers, this panel provides a multidimensional assessment of cardiovascular risk factors.
Heart disease in women often presents differently than in men, and risk assessment may require looking beyond standard cholesterol values. This advanced panel includes a Lipid Panel, Apolipoprotein A1 and Apolipoprotein B with ratio, Lipoprotein (a), and Lipoprotein Fractionation by NMR to evaluate not only cholesterol levels but also lipoprotein particle number and size. Additional markers such as hs-CRP, Homocysteine, Fibrinogen Activity, and Galectin-3 provide insight into inflammation, vascular health, and cardiac remodeling processes.
Metabolic and endocrine contributors are also addressed through Hemoglobin A1c, Insulin, Leptin, Adiponectin, TSH, and Free T4. These biomarkers help evaluate insulin resistance, adipose signaling, thyroid regulation, and overall metabolic balance. Liver and kidney health are assessed through the Comprehensive Metabolic Panel, GGT, and Cystatin C with eGFR, offering a broader understanding of organ function that may influence cardiovascular outcomes.
Nutritional and hematologic markers—including Vitamin D 25-Hydroxy and Ferritin, along with a Complete Blood Count—further enhance clinical context. Together, these biomarkers create a comprehensive women’s cardiovascular risk profile that integrates lipid metabolism, inflammation, endocrine function, vascular integrity, and metabolic health into a single, clinically actionable panel.
When and Why Someone Would Order This Panel
Advanced Cardiovascular Risk Evaluation
Women may consider this advanced cardiovascular risk panel when seeking a more detailed assessment than a standard cholesterol test provides. Traditional lipid panels measure total cholesterol, LDL, HDL, and triglycerides; however, cardiovascular risk is influenced by lipoprotein particle number, genetic factors such as Lipoprotein (a), systemic inflammation, coagulation markers, and metabolic signaling hormones. This panel may be appropriate for women with a family history of premature cardiovascular disease, elevated cholesterol levels, or previous abnormal lipid results who want a deeper understanding of their risk profile.
Evaluation of Inflammation and Vascular Health
Chronic low-grade inflammation is associated with the development of atherosclerosis. Markers such as hs-CRP, Homocysteine, Fibrinogen Activity, and Galectin-3 provide insight into inflammatory activity, endothelial stress, clotting dynamics, and cardiac tissue remodeling. Women undergoing preventive health screening, or those monitoring known cardiometabolic risk factors, may benefit from evaluating these pathways.
Assessment of Metabolic Syndrome and Insulin Resistance
Insulin resistance, altered adipokine signaling, and changes in body composition can significantly influence cardiovascular health. This panel includes Hemoglobin A1c, fasting Insulin, Leptin, and Adiponectin to assess glucose regulation and metabolic signaling. Women experiencing midlife metabolic changes, weight redistribution, or a history of gestational diabetes may consider this panel to evaluate cardiometabolic patterns.
Thyroid, Kidney, and Liver Considerations
Thyroid dysfunction can affect lipid metabolism and cardiovascular risk. TSH and Free T4 help assess thyroid regulation. Kidney function markers such as Cystatin C with eGFR and liver enzyme GGT provide additional context, as renal and hepatic health are closely linked to cardiometabolic outcomes.
Overall, this panel may be ordered as part of preventive cardiovascular screening, advanced lipid evaluation, or comprehensive cardiometabolic monitoring in women seeking a thorough assessment.
What Does the Panel Measure?
Lipid and Lipoprotein Markers
-
Lipid Panel: Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.
-
Apolipoprotein A1 (ApoA1): Major protein component of HDL particles.
-
Apolipoprotein B (ApoB): Reflects the number of atherogenic lipoprotein particles.
-
ApoB/ApoA1 Ratio: Assesses balance between atherogenic and protective particles.
-
Lipoprotein (a): Genetically influenced lipoprotein associated with cardiovascular risk.
-
Lipoprotein Fractionation NMR: Measures lipoprotein particle number and size, including LDL particle concentration.
Inflammatory and Vascular Biomarkers
-
High-Sensitivity C-Reactive Protein (hs-CRP): Marker of systemic inflammation.
-
Homocysteine: Amino acid associated with endothelial health.
-
Fibrinogen Activity: Coagulation protein linked to clotting dynamics.
-
Galectin-3: Biomarker associated with cardiac remodeling and fibrosis.
Metabolic and Endocrine Markers
-
Hemoglobin A1c: Average blood glucose over approximately three months.
-
Insulin (Fasting): Assesses insulin production and potential insulin resistance.
-
Leptin: Hormone involved in appetite regulation and adipose signaling.
-
Adiponectin: Adipokine associated with insulin sensitivity.
-
TSH and Free T4: Evaluate thyroid regulation and circulating thyroid hormone.
Organ Function and Nutrient Markers
-
Comprehensive Metabolic Panel (CMP): Glucose, electrolytes, kidney markers, liver enzymes, and protein levels.
-
GGT (Gamma-Glutamyl Transferase): Liver enzyme associated with oxidative stress and metabolic health.
-
Cystatin C with eGFR: Sensitive marker of kidney filtration.
-
Complete Blood Count (CBC): Red blood cells, white blood cells, hemoglobin, hematocrit, and platelets.
-
Vitamin D 25-Hydroxy: Indicator of vitamin D status.
-
Ferritin: Reflects iron storage levels.
Together, these markers provide a detailed cardiovascular, metabolic, inflammatory, and endocrine profile.
How Patients and Healthcare Providers Use the Results
Stratifying Cardiovascular Risk
Healthcare providers may use ApoB, Lipoprotein (a), and NMR lipoprotein particle data to refine cardiovascular risk assessment beyond traditional LDL cholesterol values. Elevated ApoB or LDL particle number may indicate increased atherogenic particle burden. Increased Lp(a) may represent genetically influenced risk. These findings can guide decisions regarding monitoring frequency, lifestyle modification, or further evaluation.
Evaluating Inflammation and Thrombotic Risk
Elevated hs-CRP, Homocysteine, or Fibrinogen Activity may suggest increased inflammatory or prothrombotic activity. Galectin-3 may provide additional insight into cardiac structural stress. These markers help contextualize overall cardiovascular risk patterns.
Identifying Insulin Resistance and Metabolic Syndrome
Patterns such as elevated fasting insulin, increased Hemoglobin A1c, high triglycerides, low HDL, elevated leptin, or low adiponectin may indicate insulin resistance or metabolic syndrome. Early identification supports preventive monitoring and risk-reduction strategies.
Assessing Thyroid, Kidney, and Liver Influence
Abnormal TSH or Free T4 may indicate thyroid dysfunction, which can affect lipid metabolism. Cystatin C with eGFR provides a sensitive assessment of kidney filtration, while GGT may reflect oxidative stress and liver health. These results allow providers to interpret cardiovascular biomarkers within a broader physiological framework.
Supporting Long-Term Monitoring
This panel may be used for baseline screening or ongoing monitoring of cardiovascular and metabolic health. By evaluating multiple interconnected systems, healthcare providers can better understand evolving trends and adjust care strategies accordingly.
An Integrated Approach to Women’s Cardiovascular and Metabolic Health
The Women’s Advanced Cardiovascular Risk Panel is designed to provide a detailed, clinically meaningful evaluation of cardiovascular risk factors in women. By combining traditional lipids with advanced particle testing, inflammatory markers, adipokines, thyroid hormones, kidney function markers, and nutrient assessments, this panel offers a comprehensive perspective on heart and metabolic health.
Cardiovascular risk is multifactorial. Lipid particle number, inflammation, insulin signaling, hormonal balance, organ function, and nutrient status all contribute to long-term outcomes. This panel integrates these dimensions into one cohesive assessment, supporting informed, evidence-based conversations between patients and healthcare providers.
Through comprehensive biomarker evaluation, women can gain a clearer understanding of their cardiovascular and metabolic profile, helping guide personalized monitoring and preventive health strategies grounded in objective laboratory data.